<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Braz. J. Microbiol</journal-id><journal-id journal-id-type="publisher-id">bjm</journal-id><journal-title-group><journal-title>Brazilian Journal of Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1517-8382</issn><issn pub-type="epub">1678-4405</issn><publisher><publisher-name>Sociedade Brasileira de Microbiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26273263</article-id><article-id pub-id-type="pmc">4507540</article-id><article-id pub-id-type="doi">10.1590/S1517-838246220130541</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medical Microbiology</subject></subj-group></article-categories><title-group><article-title>Descriptive study of onychomycosis in a hospital in S&#x000e3;o
Paulo</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ribeiro</surname><given-names>Clarissa Santos de Carvalho</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref rid="c01" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Zaitz</surname><given-names>Clarisse</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Framil</surname><given-names>Val&#x000e9;ria Maria de Souza</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Ottoboni</surname><given-names>Tha&#x000ed;ssa Santos de Carvalho</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Tonoli</surname><given-names>Melissa Santos de Carvalho</given-names></name><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Ribeiro</surname><given-names>Renata Pinheiro</given-names></name><xref ref-type="aff" rid="aff04">4</xref></contrib></contrib-group><aff id="aff01"><label>1</label>Faculdade de Ci&#x000ea;ncias M&#x000e9;dicas da Santa Casa
S&#x000e3;o Paulo, Departamento de Dermatologia, Faculdade de Ci&#x000ea;ncias M&#x000e9;dicas, Santa Casa de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brasil, Departamento de Dermatologia, Faculdade de
Ci&#x000ea;ncias M&#x000e9;dicas, Santa Casa de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brazil.</aff><aff id="aff02"><label>2</label>Faculdade de Medicina de
Itajub&#x000e1;, Faculdade de Medicina de Itajub&#x000e1;, Itajub&#x000e1;, MG, Brasil, Faculdade de Medicina de Itajub&#x000e1;, Itajub&#x000e1;, MG,
Brazil.</aff><aff id="aff03"><label>3</label>Universidade Estadual Paulista, Universidade Estadual Paulista, S&#x000e3;o Jos&#x000e9; dos Campos, SP, Brasil, Universidade Estadual Paulista, S&#x000e3;o Jos&#x000e9; dos
Campos, SP, Brazil.</aff><aff id="aff04"><label>4</label>Universidade Federal de Alfenas, Universidade Federal de Alfenas, Alfenas, MG, Brasil, Universidade Federal de Alfenas, Alfenas, MG,
Brazil.</aff><author-notes><corresp id="c01">Send correspondence to C.S.C. Ribeiro. Departamento de
Dermatologia, Faculdade de Ci&#x000ea;ncias M&#x000e9;dicas, Santa Casa de S&#x000e3;o Paulo, S&#x000e3;o Paulo,
SP, Brazil. E-mail: <email>clarissascr@gmail.com</email>.</corresp><fn id="fn01" fn-type="other"><p>Associate Editor: Carlos Pelleschi Taborda</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><volume>46</volume><issue>2</issue><fpage>485</fpage><lpage>492</lpage><history><date date-type="received"><day>17</day><month>6</month><year>2013</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015, Sociedade Brasileira de
Microbiologia</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>All the content of the journal, except where otherwise noted, is
licensed under a Creative Commons License CC BY-NC.</license-p></license></permissions><abstract><p>Onychomychosis, a nail fungus infection is the most frequent nail ailment,
constituting about half of all nail disorders. It can be caused by
dermatophytes, non-dermatophytes, yeasts and <italic>Prothoteca</italic> spp.
Methods include 5407 samples of patients with suspected onychomycosis, studied
from January 2002 to December 2006, by direct mycological examination and fungi
culture. The diagnosis of onychomycosis was confirmed in samples from 3822
direct mycological and/or culture positive. The diagnosis was established by
culture for fungi. Among the 1.428 identified agents, the dermatophytes were
responsible for 68.6% (N = 980) of cases, followed by yeasts with 27.6% (N =
394), non-dermatophytes fungi with 2.2% (N = 31), <italic>Prothoteca</italic>
spp with 0.1% (N = 2), and associations with 1.5% (N = 22). Females were more
affected, with 66% (N = 2527) of cases, and the most affected age group ranged
from 31 to 60 years of age (median 47 years). Fungal microbiota is often changed
in the world, both quantitatively and qualitatively, and is affected by several
environmental factors. Thus, the periodic review of the composition of this
microbiota is important to evaluate the epidemiology and thus proportion a
better therapeutic response.</p></abstract><kwd-group><kwd>onychomycosis</kwd><kwd>dermatophytes</kwd><kwd>yeasts</kwd><kwd>non-dermatophytes fungi</kwd><kwd><italic>Prothoteca</italic> spp</kwd></kwd-group><counts><fig-count count="3"/><table-count count="2"/><equation-count count="0"/><ref-count count="40"/><page-count count="8"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Onychomycosis is a fungal nail infection which can be caused by dermatophytes, yeast,
non-dermatophyte filamentous fungi (NDFF) and currently <italic>Prototheca</italic>
spp, affecting approximately 8% of the world population (<xref rid="B10" ref-type="bibr">Effendy I <italic>et al.</italic>, 2005</xref>; <xref rid="B40" ref-type="bibr">Zaitz C <italic>et al.</italic>, 2006</xref>).</p><p>This nail ailment represents 30% of the fungal surface and around 50% of nail
diseases (<xref rid="B14" ref-type="bibr">Ghannoum MA <italic>et al.</italic>,
2000</xref>). The main onychomycosis etiologic agents are dermatophytes, which
are isolated in 75% of cases. Candida yeasts occur in around 18&#x02013;20% of cases and
NDFF reach percentages ranging from one to five percent of cases (<xref rid="B02" ref-type="bibr">Agarwalla A <italic>et al.</italic>, 2006</xref>).</p><p>Epidemiological studies of onychomycosis can provide divergent results in the
literature due to several factors, such as environmental factors and related to the
host ones. Key environmental factors considered include: urban development,
industrialization, geographical location and climatic conditions such as temperature
and exposure to ultraviolet rays. Those factors related to the host are cited in the
literature as being: age, lifestyle, occupation, sex, color, and chronic diseases
(<xref rid="B35" ref-type="bibr">Sigurgeirsson B <italic>et al.</italic>,
2000</xref>).</p><p>Onychomycosis is considered a public health problem due to high prevalence associated
to morbidities such as diabetes, impaired peripheral circulation, ungueal trauma
repetition, immunodeficiencies (<xref rid="B12" ref-type="bibr">Elewski BE,
1998</xref>). It is a disease which does not demand compulsory notification,
thus making it difficult to access the extent of the problem in our midst. Thus,
onychomycosis affects the quality of a patient's life and causes esthetic losses,
reflecting directly on self-esteem, vanity, social discrimination and the patient's
working potential (<xref rid="B21" ref-type="bibr">Lopes JO <italic>et al.</italic>,
1999</xref>).</p><p>Although nail infections are common, nowadays they are associated with difficult
treatment and are reported as having high rates of recurrence and therapeutic
inefficacy. The knowledge of ecology, etiology and distribution of the biota of the
main etiological agents allows for a better comprehension of natural history,
evolution and may contribute in the future for new therapeutic modalities (<xref rid="B31" ref-type="bibr">Schroeff J <italic>et al.</italic>, 1992</xref>).</p><p>In this retrospective study, an analysis of all positive mycological examinations
from patients with clinical onychomycosis diagnosis from the S&#x000e3;o Paulo Hospital
Dermatology Department's Mycology Laboratory was performed, covering a period from
January 2002 to December 2006</p><p>The objectives were: 1) To analyze the sensitivity of a diagnostic laboratory for
onychomycosis in the S&#x000e3;o Paulo Hospital Dermatology Department's Medical Mycology
Laboratory. 2) To analyze the distribution of cases of onychomycosis in relation to
demographic data: age and sex. 3) To analyze the distribution of onychomycosis cases
according to the main etiological agents: dermatophytes, non dermatophyte
filamentous fungi (NDFF), protists and yeasts.</p></sec><sec sec-type="materials|methods"><title>Material and Methods</title><p>This paper includes a descriptive study conducted at the S&#x000e3;o Paulo Hospital
Dermatology Department, by reviewing the results of mycological examinations
performed from January 2002 to December 2006.</p><p>All patients seen at the dermatology ambulatory that presented, among the possible
diagnoses, a clinical suspicion of onychomycosis, were submitted to mycological
examination in order to confirm the onychomycosis diagnosis.</p><p>Reagents, culture media, equipment and consumable material are routinely used in the
medical mycology laboratory of the Dermatology Department in Hospital in S&#x000e3;o Paulo.
The study was approved by the Ethics and Research Committee of the S&#x000e3;o Paulo
Hospital.</p><sec><title>Laboratory procedures</title><sec><title>Direct microscopic examination</title><p>The material was obtained by scraping with a dental explorer, a dental
curette nail and examined between a slide and coverslip after clarification
with potassium hydroxide with 20% dimethyl sulphoxide added (<xref rid="B20" ref-type="bibr">Lacaz CS <italic>et al.</italic>, 2002</xref>; <xref rid="B34" ref-type="bibr">Sidrim JJC and Rocha MFG, 2004</xref>).</p></sec><sec><title>Culture</title><p>Macroscopic aspects: The culture media for isolation and analysis of
morphological species of Dermatophytes are Sabouraud's medium with
chloramphenicol and Sabouraud medium with cycloheximide. Non-dermatophyte
filamentous fungi, yeast and <italic>Prototheca</italic> spp are grown on
Sabouraud cloranfenicol. In our laboratory, the material was inoculated into
three tubes of the means mentioned: first, collection of clinical material
and isolation of agents; second, collection of clinical material after the
first seven days from the initial collection and isolation of the agent; the
third collection of clinical material after seven days from the second
collection and isolation of agents. The growth period to occur during the
full maturity of fungal structures is: dermatophytes and NDFF observed
around 15 days, <italic>Prototheca</italic> spp and yeast about seven days
(<xref rid="B20" ref-type="bibr">Lacaz CS <italic>et al.</italic>,
2002</xref>; <xref rid="B34" ref-type="bibr">Sidrim JJC and Rocha MFG,
2004</xref>).</p><p>Microscopic aspects: The technique of microculture on slides with a culture
medium with agar-cornmeal for the identification and determination of genus
and species of dermatophytes, yeasts and NDFF was used. In
<italic>Prototheca</italic> spp, an inoculum of the culture was
withdrawn to be identified and was placed on a slide with lacto-phenol blue
dye cotton. It was possible to observe the shaped structures of morula.
Species identification is performed through biochemical tests. (<xref rid="B20" ref-type="bibr">Lacaz CS <italic>et al.</italic>, 2002</xref>;
<xref rid="B34" ref-type="bibr">Sidrim JJC and Rocha MFG,
2004</xref>).</p></sec></sec><sec><title>Statistical analysis</title><p>To analyze the results, the chi-square test in MINITAB 14 and tables in EXCEL
2007 were used for characterization of the Clinical sample material obtained
from nails of patients with suspected onychomycosis. This was done to evaluate
the association between the variables of age, gender, test result, the affected
site and agent. In all tests, the 0.05 significance level was set.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Characterization of the samples studied</title><sec><title>Direct microscopic examination and culture</title><p>Between January 2002 and December 2006, 5407 mycological tests were carried
out with clinical suspicion of onychomycosis in 3541 patients of any age,
sex and race, which were analyzed by direct microscopic examination and/or
culture. Of the total amount tested, 71% (3.822/5.407) were positive for
laboratory diagnosis of onychomycosis. Of the remaining mycological
examinations that were analyzed, 29% (1585/5407) were negative.</p><p>The distribution of mycological examinations analyzed (<xref rid="f01" ref-type="fig">Figure 1</xref>) was based on laboratory confirmed cases
of onychomycosis using direct microscopic examination and culture (both are
criteria to define positivity).</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Distribution of 3822 direct microscopic examination and cultures
in patients with clinical diagnosis of onychomycosis in the Mycology
Laboratory of the S&#x000e3;o Paulo Hospital Clinical Dermatology Department
between January 2002 and December 2006.</title></caption><graphic xlink:href="1517-8382-bjm-46-2-485-gf01"/></fig></sec><sec><title>Onychomycosis age and gender</title><p>Regarding age, it was observed in the table below that among the 3822 samples
with a diagnosis of onychomycosis, 60% (2.287/3.822) presented data on age,
with a minimum age of three months (0.25 years) and the maximum age of 98
years. The mean age was 46.9 years, standard deviation &#x000b1; 17.02; observing a
coefficient of variation of 36.3%, concluding that the most representative
of the age of this population would be the median: 47 years old.</p><p>The total distribution of patient samples analyzed in relation to age is
shown in <xref rid="f02" ref-type="fig">Figure 2</xref>. Most samples of
patients (60%) are aged from 31 to 60 years.</p><fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Age distribution of patient samples with clinical and laboratory
of onychomycosis in the Mycology Laboratory of the Dermatology
Department the S&#x000e3;o Paulo Hospital between January 2002 and December
2006.</title></caption><graphic xlink:href="1517-8382-bjm-46-2-485-gf02"/></fig><p>In terms of the distribution in relation to sex of the 3822 mycological
positive tests for laboratory diagnosis of onychomycosis, 2527 patients were
female (66%) and 1295 were male (34%).</p><p>
<xref rid="t01" ref-type="table">Table 1</xref> shows the distribution
according to age and sex in cases of onychomycosis.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><title>Distribution of samples from patients with clinical and
laboratory of onychomycosis in the mycology laboratory of the Clinic
Dermatology, at the S&#x000e3;o Paulo Hospital in the period between January
2002 and December 2006, regarding both age and sex.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Age</th><th colspan="2" valign="bottom" align="center" rowspan="1">Positive
results</th><th valign="bottom" align="center" rowspan="1" colspan="1">Total</th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th colspan="2" valign="bottom" align="left" rowspan="1">
<hr/>
</th><th valign="bottom" align="center" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1"/></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">Female</th><th valign="bottom" align="center" rowspan="1" colspan="1">Male</th><th valign="bottom" align="center" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">0&#x02013;10</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">1.05%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">11&#x02013;20</td><td valign="top" align="center" rowspan="1" colspan="1">65</td><td valign="top" align="center" rowspan="1" colspan="1">38</td><td valign="top" align="center" rowspan="1" colspan="1">103</td><td valign="top" align="center" rowspan="1" colspan="1">4.50%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">21&#x02013;30</td><td valign="top" align="center" rowspan="1" colspan="1">165</td><td valign="top" align="center" rowspan="1" colspan="1">106</td><td valign="top" align="center" rowspan="1" colspan="1">271</td><td valign="top" align="center" rowspan="1" colspan="1">11.85%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">31&#x02013;40</td><td valign="top" align="center" rowspan="1" colspan="1">207</td><td valign="top" align="center" rowspan="1" colspan="1">141</td><td valign="top" align="center" rowspan="1" colspan="1">348</td><td valign="top" align="center" rowspan="1" colspan="1">15.22%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">41&#x02013;50</td><td valign="top" align="center" rowspan="1" colspan="1">391</td><td valign="top" align="center" rowspan="1" colspan="1">122</td><td valign="top" align="center" rowspan="1" colspan="1">513</td><td valign="top" align="center" rowspan="1" colspan="1">22.43%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">51&#x02013;60</td><td valign="top" align="center" rowspan="1" colspan="1">345</td><td valign="top" align="center" rowspan="1" colspan="1">150</td><td valign="top" align="center" rowspan="1" colspan="1">495</td><td valign="top" align="center" rowspan="1" colspan="1">21.64%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">61&#x02013;70</td><td valign="top" align="center" rowspan="1" colspan="1">196</td><td valign="top" align="center" rowspan="1" colspan="1">90</td><td valign="top" align="center" rowspan="1" colspan="1">286</td><td valign="top" align="center" rowspan="1" colspan="1">12.51%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">71&#x02013;80</td><td valign="top" align="center" rowspan="1" colspan="1">124</td><td valign="top" align="center" rowspan="1" colspan="1">80</td><td valign="top" align="center" rowspan="1" colspan="1">204</td><td valign="top" align="center" rowspan="1" colspan="1">8.92%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">81&#x02013;90</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">40</td><td valign="top" align="center" rowspan="1" colspan="1">1.75%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">91&#x02013;100</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">0.13%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">1538</td><td valign="top" align="center" rowspan="1" colspan="1">749</td><td valign="top" align="center" rowspan="1" colspan="1">2287</td><td valign="top" align="center" rowspan="1" colspan="1">100%</td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><p>p &#x0003c; 0.0001 p &#x0003c; 0.05 was considered significant.</p></fn></table-wrap-foot></table-wrap><p>The chi-square statistical test, performed to evaluate the association
between the positive result of the test variables and age of the patients by
sex, showed a significant difference (p &#x0003c; 0.0001) between the percentage
of positive results observed in relation to patients age by sex, for the
level of significance; that is, the highest incidence of positive results
was in the range of 31 to 60 years for females.</p></sec><sec><title>Identification of the etiologic agents of onychomycosis</title><p>The percentage of culture isolation and identification of agents etiology was
66% (1.428/2.162) of the samples. The distribution was as follows: to 68.6%
dermatophytes (980/1.428) NDFF with 2.2% (31/1.428), yeast with 27.5%
(393/1.428), <italic>Prototheca</italic> spp 0.1% (2/1.428) and associations
between the etiologic agents such as dermatophyte + yeast 1.1% (16/1.428),
yeast + NDFF 0.4% (5/1.428), other kind of yeasts 0.1% (1/1428) (<xref rid="f03" ref-type="fig">Figure 3</xref>).</p><fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Distribution of groups of etiologic agents isolated from samples
of patients with onychomycosis at the Dermatology Department of S&#x000e3;o
Paulo Hospital between January 2002 and December 2006.</title></caption><graphic xlink:href="1517-8382-bjm-46-2-485-gf03"/></fig><p>
<xref rid="t02" ref-type="table">Table 2</xref> shows the main etiological
agents in relation to gender and species, in samples from patients with
onychomycosis. The most common dermatophyte, <italic>Trichophyton
rubrum</italic>, registered 55.7% (796/1.428); the most common NDFF was
<italic>Fusarium</italic> spp with 1.6% (23/1.428). The yeast
<italic>Candida</italic> spp was observed with 27.2% (388/1.428) and
<italic>Prototheca</italic> spp 0.1% (2/1.428).</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><title>Distribution of genera and species isolated from samples of
patients with onychomycosis at the Dermatology Department of the S&#x000e3;o
Paulo Hospital between January 2002 and December 2006.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Etiological agent</th><th valign="top" align="center" rowspan="1" colspan="1">Number of samples</th><th valign="top" align="center" rowspan="1" colspan="1">Percentage</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Dermatophyte</td><td valign="top" align="center" rowspan="1" colspan="1">980</td><td valign="top" align="center" rowspan="1" colspan="1">68.6%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Epidermophyton floccosum</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">0.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Microsporum gypseum</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">0.2%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichophyton raubistscheckii</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichophyton mentagrophytes</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">97</td><td valign="top" align="center" rowspan="1" colspan="1">6.8%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichophyton rubrum</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">796</td><td valign="top" align="center" rowspan="1" colspan="1">55.7%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichophyton</italic>
spp</td><td valign="top" align="center" rowspan="1" colspan="1">45</td><td valign="top" align="center" rowspan="1" colspan="1">3.2%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichophyton tonsurans</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">36</td><td valign="top" align="center" rowspan="1" colspan="1">2.5%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dermatophyte + Yeasts</td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">1.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichophyton
tonsurans</italic> e <italic>Candida</italic> spp</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">0.4%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichophyton
mentagrophytes</italic> e <italic>Candida</italic>
spp</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichophyton
rubrum</italic> e <italic>Candida</italic> spp</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">0.6%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichophyton</italic> spp
e <italic>Candida</italic> spp</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">NDFF</td><td valign="top" align="center" rowspan="1" colspan="1">31</td><td valign="top" align="center" rowspan="1" colspan="1">2.2%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Acremonium</italic>
spp</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Aspergillus</italic>
spp</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Fusarium</italic> spp</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">1.6%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Scytalidium hyalinum</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">0.4%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">NDFF + Yeasts</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">0.4%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Fusarium</italic> spp e
<italic>Candida</italic> spp</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">0.4%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yeasts</td><td valign="top" align="center" rowspan="1" colspan="1">394</td><td valign="top" align="center" rowspan="1" colspan="1">27.6%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Candida</italic> spp</td><td valign="top" align="center" rowspan="1" colspan="1">388</td><td valign="top" align="center" rowspan="1" colspan="1">27.2%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichosporon</italic>
spp</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">0.4%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Trichosporon</italic> spp
e <italic>Candida</italic> spp</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Protista</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">0.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<italic>Prototheca</italic>
spp</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">0.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">1428</td><td valign="top" align="center" rowspan="1" colspan="1">100.0%</td></tr></tbody></table><table-wrap-foot><fn id="TFN02"><p>p &#x0003c; 0.0001 p &#x0003c; 0.05 was considered significant.</p></fn></table-wrap-foot></table-wrap><p>The chi-square statistical test, conducted to evaluate the association
between the positive result variables of the examination and the type of
etiologic agent, showed a difference (p &#x0003c; 0.0001) between the percentage
of positive results found in the type of etiologic agent for the level of
significance, that is, a higher positive incidence refers to
dermatophytes.</p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Onychomycosis epidemiology has multifactorial influence and its prevalence is
directly related to age and other population factors, such as lifestyle and
association with other diseases. Furthermore, the distribution of pathogens, agents
of onychomycosis is not uniform, depending on several factors such as geography,
climate of the region, and population migration (<xref rid="B13" ref-type="bibr">Faergemann J, Baran R, 2003</xref>; <xref rid="B08" ref-type="bibr">Brito A,
1992</xref>).</p><p>In the S&#x000e3;o Paulo Hospital Dermatology Department's Mycology Laboratory, from January
2002 to December 2006, 5407 patients with clinical suspicion of onychomycosis were
evaluated. The laboratory diagnosis (mycological and/or culture positive) was
confirmed in 71% (3.822/5.407) of the samples analyzed. <xref rid="B11" ref-type="bibr">Elewski BE <italic>et al.</italic> in 1997</xref> observed that,
in 2065 clinical samples with suspected onychomycosis, 82% were diagnosed cases
(1.707/2.065). Gupta <italic>et al.</italic>, in a multicenter study in 2000, found
that of the 15.000 patients who had nails with some sort of abnormality, only 8% of
cases (1.199/15.000) onychomycosis were confirmed by laboratory tests. In a study
carried out by <xref rid="B07" ref-type="bibr">Brilhante <italic>et al.</italic> in
2005</xref>, of the 976 patients with suspected onychomycosis, 52% (512/976)
were confirmed as having the disease. In Belgium, 36.04% of tests confirmed presence
of onychomysis in the studied patients (1.290/3.579) (<xref rid="B05" ref-type="bibr">Arrese JE <italic>et al.</italic>, 2005</xref>). A study
conducted in India shows that of the 302 patients, 42.4% (128/302) had the diagnosis
confirmed by laboratory examination (<xref rid="B30" ref-type="bibr">Sarma S
<italic>et al.</italic>, 2008</xref>).</p><p>Of the 3822 clinical samples with direct examination and/or positive cultures
analyzed in our study, the direct microscopic examination was positive in 99.3%
(3.796/3.822) of them, while the culture was positive in 66% (1.428/2.162) of the
total samples. Studies in the literature reported 82.45% (94/114) positivity for the
direct microscopic examination, and 17.5% (20/114) for culture (<xref rid="B08" ref-type="bibr">Brito A, 1992</xref>). The author explains the difference was
due to the difficulties that the mycology laboratory went through some time,
resulting in damage to research. In 1997, a positivity of 82% (1.707/2.065) for
direct microscopic examination and 52% (1.069/2.065) for culture was observed (<xref rid="B11" ref-type="bibr">Elewski BE <italic>et al.</italic>, 1997</xref>).</p><p>Culture was performed in 56.6% (2.162/3.822) of all samples studied; it was positive
in 66% (1.428/2.162). In the studied laboratory, due to the large number of surveys
collected in the daily routine, all positive culture direct mycological examination
are not made. The cultivation limitations of all samples are the cost of the test
and the period necessary for fungus growth.</p><p>Comparing our results with the literature, it can be stated that the studied
laboratory is efficiently achieving results similar to the Mycological reference
laboratories. Besides the difficulty related to culture in all samples studied, it
was observed that the positivity obtained by direct examination is significantly
higher than that one obtained by culture. This fact can be explained by the uneven
distribution of fungi in lesions, the difficulty to collect material properly
(especially in the subungueal region) and the ease by which the contamination by
airborne fungi and bacterial microbiota, thus hindering the identification of the
true etiologic agent, due to limitations inherent in the examination, such as the
intense keratinization of nails, which makes microscopic observation of
microorganisms becomes difficult; for fungal viability, which can result in false
negative cultures and the use of antifungal medications by the patient prior to
collection (<xref rid="B09" ref-type="bibr">Carvalho MTF, 1990</xref>; <xref rid="B24" ref-type="bibr">Martelozzo IC <italic>et al.</italic>,
2005</xref>).</p><p>The age group with confirmed onychomycosis ranged from three months to 98 years of
age, with a median age of 47 years, the age group 31&#x02013;60 years, considered the
economically active population, was involved in 60% of our sample. Our results are
consistent with those of <xref rid="B25" ref-type="bibr">Martins <italic>et
al.</italic>, in 2007</xref>, who observed in a study with 184 patients, the
mean age of onset was 36 to 64 years (62%). Already, in a study with 302 patients,
it was found that onychomycosis occurred more in the age group between 21 and 30
years (36%) (<xref rid="B30" ref-type="bibr">Sarma S, 2008</xref>).</p><p>Of the 3822 positive mycological examinations for laboratory diagnosis of
onychomycosis, 2527 were from female patients (66%) and 1295 male (34%).</p><p>According to statistical analysis by chi-square test, there is a significant
difference between positive tests in both sexes. These data are consistent with the
literature, as some authors have observed that the frequency of onychomycosis
ranging from 67% to 74% in females (<xref rid="B36" ref-type="bibr">Souza EAF
<italic>et al.</italic>, 2007</xref>; <xref rid="B10" ref-type="bibr">Effendy I <italic>et al.</italic>, 2005</xref>; <xref rid="B03" ref-type="bibr">Alvarez MI <italic>et al.</italic>, 2005</xref>; <xref rid="B19" ref-type="bibr">Koussidou T <italic>et al.</italic>, 2002</xref>; <xref rid="B38" ref-type="bibr">V&#x000e9;lez A <italic>et al.</italic>, 1997</xref>; <xref rid="B18" ref-type="bibr">Kemna ME and Elewski BE, 1996</xref>; <xref rid="B29" ref-type="bibr">Sais G <italic>et al.</italic>, 1995</xref>; <xref rid="B31" ref-type="bibr">Schroeff J <italic>et al.</italic>, 1992</xref>). Other authors
found exactly the opposite, with about 64% of cases occurring in males (<xref rid="B30" ref-type="bibr">Sarma S <italic>et al.</italic>, 2008</xref>; <xref rid="B14" ref-type="bibr">Ghannoum MA <italic>et al.</italic>, 2000</xref>,
<xref rid="B35" ref-type="bibr">Sigurgeirsson B and Steingrimsson O,
2000</xref>; <xref rid="B27" ref-type="bibr">Perea S <italic>et al.</italic>,
2000</xref>). The reason for these discrepancies may lie in the composition of
the population studied, since the fungal infection depends on cultural habits and
ecology, as previously described.</p><p>Similarly the sample shows the predominance of female patients. In this sampling, the
most affected age group was between 31 and 60 years, where greater and more
significant (p &#x0003c; 0.0001) incidence of positive results was seen in the range of
31 to 60 years for females. In the literature, studies like those of <xref rid="B14" ref-type="bibr">Ghannoum <italic>et al.</italic> in 2000</xref> reported a
higher incidence of onychomycosis in the active age group with a mean age of 57
years mainly in males (58%) (1063/1832). Patients with onychomycosis were in the
range of 40&#x02013;50 years old (67.4%) of which 71% were female (179/252) (<xref rid="B25" ref-type="bibr">Martins EA <italic>et al.</italic>, 2007</xref>; <xref rid="B24" ref-type="bibr">Martelozzo IC <italic>et al.</italic>, 2005</xref>).</p><p>Some authors explain the increased prevalence of onychomycosis with aging due to some
factors, such as peripheral circulation slower, inactivity, inability to cut and
care for nails, presence of comorbidities (diabetes, repeated nail trauma, longer
exposure to pathogenic fungi, lower immunity). Moreover, the reason why the
prevalence of onychomycosis was lower in children, can be justified by quicker nail
growth, less exposure to the etiologic agents, a lower prevalence of tinea pedis and
to a lesser extent nail invasion (<xref rid="B37" ref-type="bibr">Tosti A <italic>et
al.</italic>, 2005</xref>; <xref rid="B12" ref-type="bibr">Elewski BE,
1998</xref>).</p><p>Dermatophytes are the etiological agents responsible for most onychomycosis,
representing approximately 75% of these infections (<xref rid="B01" ref-type="bibr">Afsaneh AMD <italic>et al.</italic>, 2008</xref>; <xref rid="B32" ref-type="bibr">Seebacher CJ <italic>et al.</italic>, 2007</xref>; Summerbell
RC, 2005; <xref rid="B04" ref-type="bibr">Ara&#x000fa;jo A <italic>et al.</italic>,
2003</xref>; <xref rid="B28" ref-type="bibr">Rodriguez JMT and Jodra OL,
2000</xref>; <xref rid="B16" ref-type="bibr">Gupta AK <italic>et al.</italic>,
2000</xref>; <xref rid="B39" ref-type="bibr">Weitzman I and Summerbell RC,
1995</xref>; <xref rid="B17" ref-type="bibr">Gupta AK, 1997</xref>). Some
authors found different proportions: 33.85% and 41% for dermatophytes; 13.97% and
13% for non-dermatophyte filamentous fungi and 52.17% and 46% for yeast,
respectively (<xref rid="B24" ref-type="bibr">Martelozzo <italic>et al.</italic>,
2005</xref>; <xref rid="B18" ref-type="bibr">Kemna <italic>et al.</italic>,
1996</xref>). There are few reports of onychomycosis "simile" caused by
<italic>Prototheca</italic> spp (<xref rid="B40" ref-type="bibr">Zaitz C
<italic>et al.</italic>, 2006</xref>; <xref rid="B22" ref-type="bibr">Magerman K, 1991</xref>; <xref rid="B23" ref-type="bibr">Marcano C and Feo M,
1981</xref>).</p><p>In this study, dermatophytes were the main etiologic agents isolated (68.6%
980/1.428) followed by yeast in 393 patients (27.5%), with the NDFF (2.2%); the two
<italic>Prototheca</italic> spp 0.1% cases, and finally etiological agents
associations with 1.6% (22/1428). It was observed that when the dermatophytes
species was analyzed, the <italic>T. rubrum</italic> was isolated 81.2% (796/980) of
the time, followed by <italic>T. mentagrophytes</italic> in 9.9% (97/980),
<italic>T. tonsurans</italic> in 3.6% (36/980), <italic>M. gypseum</italic> in
0.2% (3/980), <italic>E. floccosum</italic> in 0.1% (2/980) and <italic>T.
raubistscheckii</italic> in 0.1% (1/980).</p><p>On reviewing the literature, it was found that the main agents of onychomycosis are:
<italic>T. rubrum</italic>, <italic>T. mentagrophytes</italic> and <italic>T.
tonsurans</italic> (<xref rid="B14" ref-type="bibr">Ghannoum MA <italic>et
al.</italic>, 2000</xref>; <xref rid="B28" ref-type="bibr">Rodriguez JMT and
Jodra OL, 2000</xref>; <xref rid="B08" ref-type="bibr">Brito A, 1992</xref>).
<italic>T. raubistscheckii</italic> is considered by many mycologists a variant
of the <italic>T. rubrum</italic> and it is rarely isolated in the nail (<xref rid="B06" ref-type="bibr">Brasch J, 2007</xref>, <xref rid="B26" ref-type="bibr">Papini M <italic>et al.</italic>, 2004</xref>).</p><p>Furthermore, non-dermatophyte filamentous fungi (NDFF) are cited in literature as
etiologic agents of onychomycosis. In this study, <italic>Fusarium</italic> spp was
the most isolated NDFF with 74.2% (23/31). In following came the <italic>Scytalidium
hyalinum</italic> with 19.3% (6/31), <italic>Acremonium</italic> spp and
<italic>Aspergillus</italic> spp, both with 3.2% (1/31).</p><p>It was found that 13.6% of onychomycosis were caused by NDFF. The main etiologic
agent identified by the authors was <italic>Fusarium</italic> spp, 21.2% (28/132)
(<xref rid="B06" ref-type="bibr">Brasch J, 2007</xref>).</p><p>For yeast isolates, <italic>Candida</italic> spp was found in 98.5% (388/394) (<xref rid="B36" ref-type="bibr">Souza EAF <italic>et al.</italic>, 2007</xref>; <xref rid="B24" ref-type="bibr">Martelozzo IC <italic>et al.</italic>, 2005</xref>).
It was observed that the yeast Candida was most frequently isolated from cases of
onychomycosis. The <italic>Trichosporum beigelli</italic> was isolated in 1.2%
(5/394) of our cases as the etiological agent of onychomycosis by yeast and some
studies also have similar results (<xref rid="B06" ref-type="bibr">Brasch,
2007</xref>; <xref rid="B26" ref-type="bibr">Papini M <italic>et al.</italic>,
2004</xref>). Associations and fungi such as onychomycosis agents were also
found.</p><p>Dermatophyte and yeast occurred in 1.1% of cases (16/1.428) NDFF with yeast at 0.4%
of cases (5/1.428) and yeasts from other genera (not Candida) in 0.1% of cases
(1/1.428). There are few studies which mention mixed onychomycosis. Studies reported
association of onychomycosis caused by <italic>Candida</italic> spp and other fungi
in immunosuppressed patients and reported possible associations of fungi in
onychomycosis in a study of 2766 patients(<xref rid="B19" ref-type="bibr">Koussidou
T <italic>et al.</italic>, 2002</xref>). Onychomycosis "like" caused by
<italic>Prototheca</italic> spp was a peculiarity observed in our study. In
respect to this peculiarity, two patients were observed (patients with the same two
nails affected), which correspond to 0.1% of the causative agents of onychomycosis.
This case was published, the first case in Brazil of onychomycosis caused by
<italic>Prototheca</italic> spp and 3rd case in the world (<xref rid="B40" ref-type="bibr">Zaitz C <italic>et al.</italic>, 2006</xref>).</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>From January 2002 to December 2006, 3822 samples were analyzed with clinically
suspected onychomycosis which were confirmed in the laboratory and allowed for the
following conclusions:</p><list list-type="order"><list-item><p>The direct microscopic examination method is sensitive, rapid and inexpensive
for general diagnosis of onychomycosis. In spite of its culture high
specificity, it is difficult to perform, more costly and dependent on
several factors such as: collection, culture medium and the skills of the
professional who performs it.</p></list-item><list-item><p>The most affected age group in the population studied was 31 to 60 years of
age and predominantly female (66%).</p></list-item><list-item><p>The main groups of etiologic agents were isolated: dermatophytes (68.6%),
NDFF (2.2%), yeast (27.5%), <italic>Prototheca</italic> spp (0.1%) and
associations fungi (1.6%). The distribution of species most often found in
different groups of agents was: a Dermatophytes: <italic>T. rubrum</italic>
(81.2%), <italic>T. mentagrophytes</italic> (9.9%) and <italic>T.
tonsurans</italic> (3.6%), b. NDFF: <italic>Fusarium</italic> spp
(74.2%) and <italic>Scytalidium hyalinum</italic> (19.3%) c. Yeasts:
<italic>Candida</italic> spp (98.5%).</p></list-item></list></sec></body><back><ref-list><title>References</title><ref id="B01"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afsaneh</surname><given-names>AMD</given-names></name><name><surname>Woo</surname><given-names>KY</given-names></name><name><surname>Sibbald</surname><given-names>RG</given-names></name></person-group><year>2008</year><article-title>Common fungal infections of the nail</article-title><source>Can J Diagnosis</source><volume>26</volume><fpage>54</fpage><lpage>62</lpage></element-citation></ref><ref id="B02"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwalla</surname><given-names>A</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Khanal</surname><given-names>B</given-names></name></person-group><year>2006</year><article-title>Onychomycosis in eastern Nepal</article-title><source>Nepal Med Coll J</source><volume>8</volume><fpage>22</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">16827085</pub-id></element-citation></ref><ref id="B03"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>MI</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>LA</given-names></name><name><surname>Castro</surname><given-names>LA</given-names></name></person-group><year>2005</year><article-title>Onychomycosis in Cali, Col&#x000f4;mbia</article-title><source>Mycopathologia</source><volume>158</volume><fpage>181</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">15518346</pub-id></element-citation></ref><ref id="B04"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ara&#x000fa;jo</surname><given-names>A</given-names></name><name><surname>Bastos</surname><given-names>O</given-names></name><name><surname>Souza</surname><given-names>M</given-names></name></person-group><year>2003</year><article-title>Occurence of onychomycosis among patients attend in dermatology
offices in the city of Rio de Janeiro, Brazil</article-title><source>An Bras Dermatol</source><volume>79</volume><fpage>225</fpage><lpage>232</lpage></element-citation></ref><ref id="B05"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arrese</surname><given-names>JE</given-names></name><name><surname>Jenny</surname><given-names>CV</given-names></name><name><surname>Pierard</surname><given-names>GE</given-names></name></person-group><year>2005</year><article-title>Un nuevo enfoque sobre la epidemiolog&#x000ed;a de las
onicomicosis</article-title><source>Ver Iberoam Micol</source><volume>22</volume><fpage>163</fpage><lpage>166</lpage></element-citation></ref><ref id="B06"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brasch</surname><given-names>J</given-names></name></person-group><year>2007</year><article-title>Var raubitschekii of Trichophyton rubrum as a cause of tinea in
Germany</article-title><source>Mycoses</source><volume>50</volume><fpage>11</fpage><lpage>14</lpage></element-citation></ref><ref id="B07"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brilhante</surname><given-names>RSN</given-names></name><name><surname>Cordeiro</surname><given-names>RA</given-names></name><name><surname>Medrano</surname></name><etal/></person-group><year>2005</year><article-title>Onychomychosis in Cear&#x000e1; (Northeast Brazil): epidemiological and
laboratory aspects</article-title><source>Mem Inst Oswaldo Cruz</source><volume>100</volume><fpage>131</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">16021299</pub-id></element-citation></ref><ref id="B08"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>A</given-names></name></person-group><year>1992</year><article-title>Incid&#x000ea;ncia de onicomicose no Par&#x000e1; entre 1980 e
1990</article-title><source>An Bras Dermatol</source><volume>67</volume><fpage>182</fpage><lpage>183</lpage></element-citation></ref><ref id="B09"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>MTF</given-names></name></person-group><year>1990</year><source>Pesquisa de Fungos em Unhas de Pacientes HIV Soropositivos</source><comment>Dissertation</comment><publisher-name>Escola Paulista de Medicina</publisher-name><publisher-loc>S&#x000e3;o Paulo</publisher-loc></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Effendy</surname><given-names>I</given-names></name><name><surname>Lecha</surname><given-names>M</given-names></name><name><surname>Feuilhade</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Epidemiology and clinical classification of
onychomycosis</article-title><source>J Eur Acad Dermatol Venereol</source><issue>Suppl 1</issue><fpage>8</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">16120199</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elewski</surname><given-names>BE</given-names></name><name><surname>Charif</surname><given-names>MA</given-names></name></person-group><year>1997</year><article-title>Prevalence of onychomycosis in patients attending a dermatology
clinic in northeastern Ohio for other conditions</article-title><source>Arch Dermatol</source><volume>133</volume><fpage>1172</fpage><lpage>1173</lpage><pub-id pub-id-type="pmid">9301602</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elewski</surname><given-names>BE</given-names></name></person-group><year>1998</year><article-title>Onychomycosis: Pathogenesis, Diagnosis, and
Management</article-title><source>Clin Microbiol Rev</source><volume>11</volume><fpage>415</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">9665975</pub-id></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faergemann</surname><given-names>J</given-names></name><name><surname>Baran</surname><given-names>R</given-names></name></person-group><year>2003</year><article-title>Epidemiology, clinical presentation and diagnosis of
onychomycosis</article-title><source>Br J Dermatol</source><volume>149</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">14510968</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghannoum</surname><given-names>MA</given-names></name><name><surname>Hajjeh</surname><given-names>RA</given-names></name><name><surname>Scher</surname><given-names>R</given-names></name><etal/></person-group><year>2000</year><article-title>A Large-Scale North American study of fungal isolates from nails:
the frequency of onychomycosis, fungal distribution, and antifungal
susceptibility patterns</article-title><source>J Am Acad Dermatol</source><volume>43</volume><fpage>641</fpage><lpage>648</lpage><pub-id pub-id-type="pmid">11004620</pub-id></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>AK</given-names></name><name><surname>Hem</surname><given-names>CJ</given-names></name><name><surname>Lynde</surname><given-names>CW</given-names></name><etal/></person-group><year>2001</year><article-title>Prevalence and epidemiology of onychomycosis in patients visiting
physicians offices: a multicenter Canadian survey of 15000
patients</article-title><source>J Am Acad Dermatol</source><volume>43</volume><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">10906646</pub-id></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>AK</given-names></name><name><surname>Gupta</surname><given-names>MA</given-names></name><name><surname>Summerbell</surname><given-names>MC</given-names></name></person-group><year>2000</year><article-title>The epidemiology of onychomycosis possible role of smoking and
peripheral arterial disease</article-title><source>J Eur Acad Dermatol Venereol</source><volume>14</volume><fpage>466</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">11444267</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>AK</given-names></name><name><surname>Jain</surname><given-names>HC</given-names></name><name><surname>Lynde</surname><given-names>CW</given-names></name><etal/></person-group><year>1997</year><article-title>Prevalence and epidemiology of unsuspected onychomycosis in
patients visiting dermatologists offices in Ontario, Canada - A multicenter
survey of 2001 patients</article-title><source>Int J Dermatol</source><volume>36</volume><fpage>783</fpage><lpage>787</lpage><pub-id pub-id-type="pmid">9372358</pub-id></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemna</surname><given-names>ME</given-names></name><name><surname>Elewski</surname><given-names>BE</given-names></name></person-group><year>1996</year><article-title>A U.S. epidemiologic survey of superficial fungal
diseases</article-title><source>J Am Acad Dermatol</source><volume>35</volume><fpage>539</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">8859279</pub-id></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koussidou</surname><given-names>T</given-names></name><name><surname>Devliotou-Panagiotidou</surname><given-names>D</given-names></name><name><surname>Karakatsanis</surname><given-names>G</given-names></name><etal/></person-group><year>2002</year><article-title>Onychomycosis in Northern Greece during 1994&#x02013;1998</article-title><source>Mycoses</source><volume>45</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">11856434</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lacaz</surname><given-names>CS</given-names></name><name><surname>Porto</surname><given-names>E</given-names></name><name><surname>Martins</surname><given-names>JEC</given-names></name><etal/></person-group><year>2002</year><source>Tratado de Micologia M&#x000e9;dica</source><edition>9 ed.</edition><publisher-loc>S&#x000e3;o Paulo</publisher-loc><publisher-name>Sarvier</publisher-name><fpage>31</fpage><lpage>58</lpage></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>JO</given-names></name><name><surname>Alves</surname><given-names>SH</given-names></name><name><surname>Mari</surname><given-names>CRD</given-names></name><etal/></person-group><year>1999</year><article-title>A ten-year survey of onychomycosis in the central region of the
Rio Grande do Sul, Brazil</article-title><source>Rev Inst Med Trop Sao Paulo</source><volume>41</volume><fpage>147</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">10529831</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magerman</surname><given-names>K</given-names></name><name><surname>Gordts</surname><given-names>B</given-names></name><name><surname>Hindryckx</surname><given-names>P</given-names></name><etal/></person-group><year>1991</year><article-title>Isolation of Prothoteca zopfii from a finger. Case report and
review of the literature</article-title><source>Acta Clin Belg</source><volume>46</volume><fpage>233</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">1659090</pub-id></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcano</surname><given-names>C</given-names></name><name><surname>Feo</surname><given-names>M</given-names></name></person-group><year>1981</year><article-title>Prothoteca zopfii colonizing the nail</article-title><source>Mycopathologia</source><volume>75</volume><fpage>89</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">7278940</pub-id></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martelozzo</surname><given-names>IC</given-names></name><name><surname>GuilhermettiI</surname><given-names>E</given-names></name><name><surname>Svidzinski</surname><given-names>TIE</given-names></name></person-group><year>2005</year><article-title>Ocorr&#x000ea;ncia de onicomicose em Maring&#x000e1;, Estado do Paran&#x000e1;,
Brasil</article-title><source>Acta Scientiarum: Health Science</source><volume>27</volume><fpage>177</fpage><lpage>182</lpage></element-citation></ref><ref id="B25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>EA</given-names></name><name><surname>Guerrer</surname><given-names>LV</given-names></name><name><surname>Cunha</surname><given-names>KC</given-names></name><etal/></person-group><year>2007</year><article-title>Onicomicose: estudo cl&#x000ed;nico, epidemiol&#x000f3;gico e micol&#x000f3;gico no
munic&#x000ed;pio de S&#x000e3;o Jos&#x000e9; do Rio Preto</article-title><source>Rev Soc Bras Med Trop</source><volume>40</volume><fpage>596</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">17992422</pub-id></element-citation></ref><ref id="B26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papini</surname><given-names>M</given-names></name><name><surname>Greco</surname><given-names>C</given-names></name><name><surname>Pileri</surname><given-names>F</given-names></name></person-group><year>2004</year><article-title>Onychomycosis caused by an isolate conforming to the description
of Trichophyton raubitschekii</article-title><source>Med Mycol</source><volume>42</volume><fpage>273</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">15283242</pub-id></element-citation></ref><ref id="B27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perea</surname><given-names>S</given-names></name><name><surname>Ramos</surname><given-names>MJ</given-names></name><name><surname>Garau</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Prevalence and risk factors of Tinea unguium and Tinea pedis in
the general population in Spain</article-title><source>J Clin Microbiol</source><volume>38</volume><fpage>3226</fpage><lpage>3230</lpage><pub-id pub-id-type="pmid">10970362</pub-id></element-citation></ref><ref id="B28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>JMT</given-names></name><name><surname>Jodra</surname><given-names>OL</given-names></name></person-group><year>2000</year><article-title>Epidemiology of nail infection due to keratinophilic
fungi</article-title><source>Rev I Am Micol</source><volume>17</volume><fpage>05</fpage><lpage>07</lpage></element-citation></ref><ref id="B29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sais</surname><given-names>G</given-names></name><name><surname>Jucgl&#x000e0;</surname><given-names>A</given-names></name><name><surname>Peyr&#x000ed;</surname><given-names>J</given-names></name></person-group><year>1995</year><article-title>Prevalence of dermatophyte onychomycosis in Spain, a
cross-sectional study</article-title><source>Br J Dermatol</source><volume>132</volume><fpage>758</fpage><lpage>761</lpage><pub-id pub-id-type="pmid">7772481</pub-id></element-citation></ref><ref id="B30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarma</surname><given-names>S</given-names></name><name><surname>Cappor</surname><given-names>MR</given-names></name><name><surname>Deb</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>Epidemiologic and clinicomycologic profile of onychomycosis from
north India</article-title><source>Int J Dermatol</source><volume>47</volume><fpage>584</fpage><pub-id pub-id-type="pmid">18477149</pub-id></element-citation></ref><ref id="B31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeff</surname><given-names>J</given-names></name><name><surname>Girkel</surname><given-names>P</given-names></name><name><surname>Crijns</surname><given-names>M</given-names></name><etal/></person-group><year>1992</year><article-title>A randomized treatment duration finding study of terbinafine in
onychomycosis</article-title><source>Br J Dermatol</source><volume>126</volume><fpage>S36</fpage><lpage>39</lpage></element-citation></ref><ref id="B32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seebacher</surname><given-names>CJ</given-names></name><name><surname>Brash</surname><given-names>DA</given-names></name><name><surname>Cornely</surname><given-names>O</given-names></name><etal/></person-group><year>2007</year><article-title>Guideline of onychomycosis</article-title><source>Mycoses</source><volume>50</volume><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">17576328</pub-id></element-citation></ref><ref id="B33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoar</surname><given-names>MG</given-names></name><name><surname>Zomorodian</surname><given-names>K</given-names></name><name><surname>Emami</surname><given-names>M</given-names></name><etal/></person-group><year>2002</year><article-title>Study and Identification of the Etiological Agents of
Onychomycosis in Tehran, Capital of Iran</article-title><source>Iranian J Publ Health</source><volume>31</volume><fpage>01</fpage><lpage>04</lpage></element-citation></ref><ref id="B34"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sidrim</surname><given-names>JJC</given-names></name><name><surname>Rocha</surname><given-names>MFG</given-names></name></person-group><year>2004</year><source>Micologia M&#x000e9;dica a Luz de Autores Contempor&#x000e2;neos</source><publisher-name>Guanabara Koogan</publisher-name><publisher-loc>Rio de Janeiro</publisher-loc><fpage>97</fpage><lpage>113</lpage></element-citation></ref><ref id="B35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigurgeirsson</surname><given-names>B</given-names></name><name><surname>Steingrimsson</surname><given-names>O</given-names></name></person-group><year>2000</year><article-title>Risk factors associated with onychomycosis</article-title><source>J Eur Acad Dermatol Venereol</source><volume>14</volume><fpage>466</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">11444267</pub-id></element-citation></ref><ref id="B36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>EAF</given-names></name><name><surname>Mota</surname><given-names>VA</given-names></name><name><surname>Almeida</surname><given-names>LMM</given-names></name><etal/></person-group><year>2007</year><article-title>Frequencia de onicomicoses por leveduras em Maring&#x000e1;, Paran&#x000e1;,
Brasil</article-title><source>An Bras Dermatol</source><volume>82</volume><fpage>02</fpage><lpage>06</lpage></element-citation></ref><ref id="B37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosti</surname><given-names>A</given-names></name><name><surname>Hay</surname><given-names>R</given-names></name><name><surname>Arenas</surname><given-names>R</given-names></name></person-group><year>2005</year><article-title>Patients at risk of onychomycosis - risk factor identification
and active prevention</article-title><source>J Eur Acad Dermatol Venereol</source><volume>19</volume><fpage>13</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">16120200</pub-id></element-citation></ref><ref id="B38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e9;lez</surname><given-names>A</given-names></name><name><surname>Linares</surname><given-names>MJ</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>JC</given-names></name><etal/></person-group><year>1997</year><article-title>Study of onychomycosis in Cordoba, Spain: prevailing fungi and
pattern of infection</article-title><source>Mycopathologia</source><volume>137</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9299751</pub-id></element-citation></ref><ref id="B39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weitzman</surname><given-names>I</given-names></name><name><surname>Summerbell</surname><given-names>RC</given-names></name></person-group><year>1995</year><article-title>The dermatophytes</article-title><source>Clin Microbiol Rev</source><volume>8</volume><fpage>240</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">7621400</pub-id></element-citation></ref><ref id="B40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaitz</surname><given-names>C</given-names></name><name><surname>Godoy</surname><given-names>A</given-names></name><name><surname>Sousa</surname><given-names>V</given-names></name></person-group><year>2006</year><article-title>Onychoprothecosis: Report of the first case in
Brazil</article-title><source>The Int J Dermatol</source><volume>45</volume><fpage>1071</fpage><lpage>1073</lpage><pub-id pub-id-type="pmid">16961512</pub-id></element-citation></ref></ref-list></back></article>